<h1>Anticipatory Bail Denied in $18.8M Counterfeit Drug Scam Threatening Public Health and Global Reputation</h1> A Delhi court dismissed the anticipatory bail plea of an individual accused in a multi-million dollar international scam involving counterfeit anti-diabetic drugs supplied to foreign entities. The court emphasized the threat such pharmaceutical crimes pose to public health and India's reputation as a global pharmaceutical leader. The accused was linked to a sophisticated transnational fraud causing losses exceeding USD 18.8 million and involved complex money laundering and criminal conspiracy. The court highlighted the accused as a significant flight risk with potential to tamper with evidence and intimidate witnesses. It held that anticipatory bail is inappropriate in cases involving grave offenses against public health with international implications, requiring custodial interrogation and international cooperation. The court instructed that arrest should be a last resort, limited to investigative necessity, underscoring the importance of maintaining legal compliance and integrity in the pharmaceutical sector.